Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 13, 2025 • 3:00 AM ET

Date/Time Source News Release
08/12/2025 04:30 PM EDT PR Newswire Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
08/06/2025 08:30 AM EDT Canada Newswire Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
07/17/2025 04:30 PM EDT PR Newswire Citius Oncology Announces Closing of $9.0 Million Public Offering
07/16/2025 09:15 AM EDT PR Newswire Citius Oncology Announces Pricing of $9.0 Million Public Offering
07/15/2025 08:32 AM EDT PR Newswire Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora
06/17/2025 08:08 AM EDT PR Newswire Citius Oncology Anticipates Commercial Launch of LYMPHIR(TM) in 2025
06/09/2025 08:37 AM EDT PR Newswire Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
05/14/2025 04:30 PM EDT PR Newswire Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
02/14/2025 04:30 PM EST PR Newswire Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
02/06/2025 08:55 AM EST PR Newswire Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Page